XML 15 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 37,870 $ 65,064
Marketable securities 122,084 79,738
Accounts receivable (net of allowance of $35 at both March 31, 2016 and December 31, 2015) 4,865 6,978
Inventories 5,312 4,155
Research and development tax credit receivable - current portion 368 2,382
Prepaid expenses and other current assets 9,975 7,989
Total current assets 180,474 166,306
Property and equipment, net 3,100 2,616
Goodwill 24,055 18,491
Intangible assets, net 32,911 15,825
Research and development tax credit receivable - less current portion 2,490 0
Income tax deferred charge 11,964 11,581
Other 16 158
Total assets 255,010 214,977
Current liabilities:    
Current portion of long-term debt 454 434
Current portion of long-term related party contingent consideration payable 28,403 28,614
Accounts payable 17,674 10,565
Deferred revenue 4,611 5,121
Accrued expenses 3,346 3,598
Income taxes 5,844 323
Other 611 133
Total current liabilities 60,943 48,788
Long-term debt, less current portion 710 684
Long-term related party contingent consideration payable, less current portion 102,656 94,079
Long-term related party payable 15,000 0
Deferred taxes 3,507 1,351
Other 2,495 2,210
Total liabilities 185,311 147,112
Shareholders' equity:    
Ordinary shares, nominal value of 0.122 euro per share; 53,178 shares authorized; 41,241 issued and outstanding at March 31, 2016 and December 31, 2015, respectively 6,331 6,331
Additional paid-in capital 366,459 363,984
Accumulated deficit (286,169) (279,793)
Accumulated other comprehensive loss (16,922) (22,657)
Total shareholders' equity 69,699 67,865
Total liabilities and shareholders' equity $ 255,010 $ 214,977